Articles dans des revues avec comité de lecture (349)
  1. 248. Delvenne, V., Goldman, S., De Maertelaer, V., & Lotstra, F. (1999). Brain glucose metabolism in eating disorders assessed by positron emission tomography. The International journal of eating disorders, 25(1), 29-37. doi:10.1002/(SICI)1098-108X(199901)25:1<29::AID-EAT4>3.0.CO;2-#
  2. 249. Dethy, S., Laute, M.-A., Damhaut, P., & Goldman, S. (1999). Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine. Journal of neural transmission (Vienna, Austria : 1996), 106(2), 145-158. doi:10.1007/s007020050147
  3. 250. Plenevaux, A., Lemaire, C., Salmon, E., Laureys, S., Fuchs, S., Maquet, P., Degueldre, C., Aerts, J., Brihaye, C., Damhaut, P., Biver, F., Goldman, S., Le Bars, D., Ginovart, N., Cinotti, L., Pujol, J. F., & Luxen, A. (1999). 5-HT(1A) receptors visualization with p-[18F]MPPF in healthy volunteers. Journal of labelled compounds & radiopharmaceuticals, 42(SUPPL. 1), S60-S62.
  4. 251. Damhaut, P., Monclus, M., Van Gasbeke, B., Schmitz, F., Ghyoot, M., Verbruggen, R., Mulleneers, E., Van Naemen, J., Vamecq, F., Destexhe, C., Jongen, Y., & Goldman, S. (1999). Quality assurance and quality controls in the routine production of [13N]NH4+ using the 16O(p,α)13N nuclear reaction. Journal of labelled compounds & radiopharmaceuticals, 42(SUPPL. 1), S867-S869.
  5. 252. Monclus, M., Damhaut, P., Luxen, A., Velu, T., & Goldman, S. (1999). In vitro validation of (R)- and (S)-9-{(1-[18F]flouro-3-hydroxy-2-propoxy)methyl}guanine as radiopharmaceuticals for gene therapy. Journal of labelled compounds & radiopharmaceuticals, 42(SUPPL. 1), S627-S629.
  6. 253. Monclus, M., Damhaut, P., Kuhnast, B., Tavitian, B., Hantraye, P., Velu, T., Luxen, A., & Goldman, S. (1999). In vivo validation in rat and monkey of RAC-9-{(1-[18F]flouro-3-hydroxy-2-propoxy)methyl}guanine: A radiopharmaceutical for gene therapy. Journal of labelled compounds & radiopharmaceuticals, 42(SUPPL. 1), S10-S12.
  7. 254. Damhaut, P., Plenevaux, A., Lemaire, C., Aerts, J., Biver, F., Monclus, M., Luxen, A., & Goldman, S. (1999). In vivo studies of p-[18F]MPPF metabolites in human. Journal of labelled compounds & radiopharmaceuticals, 42(SUPPL. 1), S661-S662.
  8. 255. Van Bogaert, P., David, P., Gillain, C., Wikler, D., Damhaut, P., Scalais, E., Nuttin, C., Wetzburger, C., Szliwowski, H., Metens, T., & Goldman, S. (1998). Perisylvian dysgenesis. Clinical, EEG, MRI and glucose metabolism features in 10 patients. Brain, 121(12), 2229-2238. doi:10.1093/brain/121.12.2229
  9. 256. De Witte, O., Levivier, M., Violon, P., Brotchi, J., & Goldman, S. (1998). Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery, 43(2), 398-399.
  10. 257. Van Bogaert, P., Wikler, D., Damhaut, P., Szliwowski, H., & Goldman, S. (1998). Regional changes in glucose metabolism during brain development from the age of 6 years. NeuroImage, 8(1), 62-68. doi:10.1006/nimg.1998.0346
  11. 258. Tecco, J. M., Wuilmart, P., Lasseaux, L., Wikler, D., Damhaut, P., Goldman, S., & Gilles, C. (1998). Cerebello-thalamo-cerebral diaschisis: a case report. Journal of neuroimaging, 8(2), 115-116. doi:10.1111/jon199882115
  12. 259. Dethy, S., Van Blercom, N., Damhaut, P., Wikler, D., Hildebrand, J., & Goldman, S. (1998). Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism. Movement disorders, 13(2), 275-280. doi:10.1002/mds.870130213
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 40 41 42 43 44 45 Suivant >>